References
- Derynck R. Transforming growth factor alfa. Cell 1988; 54: 594–5
- Bates S., Davidson N., Valverius E., et al. Expression of transforming growth factor alfa and its messenger ribonuklei acid in human breast cancer: its regulation by estrogen and its possible funktional significance. Mol Endocrinol 1988; 2: 543–55
- Lupu R., Wellstein A., Sheridan J., et al. Purification and characterization of a novel growth factor from human breast cancer cells. Biochemistry 1992; 31: 7330–40
- Salomon D., Zwiebel J., Bano M., Losonczy I., Fehnel P., Kidwell W. Presence of transforming growth factor in human breast cancer cells. Cancer Res 1984; 44: 4069–77
- Ahmed S., Badger B., Wright C., Manni A. Role of transforming growth factor-α (TGF-α) in basal and hormone-stimulated growth by estradiol prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-α and EGF receptor antibodies. J Steroid Biochem Molec Biol 1991; 38: 687–93
- Marquardt H., Hunkapiller M. W., Hood L., Todaro G. Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 1984; 223: 1079–82
- Auvinen P., Lipponen P., Johansson R., Syrjänen K. Prognostic significance of TGF-β1 and TGF-β2 expressions in female breast cancer. Anticancer Res 1995; 15: 2627–32
- Auvinen P., Lipponen P., Johansson R., Syrjänen K. Prognostic significance of TGF-β2 expression in female breast cancer. Eur J Cancer 1995; 31: 831
- WHO. Histologic typing of breast tumours. International histological classification of tumours No2, 2nd. World Health Organization, Geneva 1981
- Bloom H., Richardson W. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–77
- Eskelinen M., Lipponen P., Papinaho S., et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 1992; 51: 555–61
- Vihko R., Jänne O., Kontula R., Syrjälä P. Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels. Int J Cancer 1980; 26: 13–21
- Tervahauta A., Syrjänen S., Yliskoski M., Gold L., Syrjänen K. Expression of transforming growth factor-β1 and -β2 in human papillomavirus (HPV)- associated lesions of uterine cervix. Gynecol Oncol 1994; 54: 349–56
- Kaplan E., Meier P. Nonparametric estimates for incomplete observations. J Am Stat Assoc 1958; 53: 456–81
- Cox D. Regression models and life tables with discussion. J R Stat Doc B 1972; 34: 187–220
- Ciardiello F., Kim N., McGeady, et al. Expression of transforming growth factor alpha (TGFα) in breast cancer. Annals of Oncology 1991; 2: 169–82
- Panico L., Dantonio A., Salvatore G., et al. Differential im-munohistochemical detection of transforming growth factor α amphiregulin and cripto in human normal and malignant breast tissues. Int J Cancer 1996; 65: 51–6
- Umekita Y., Enokizono N., Sagara Y., et al. Immunohisto-chemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status. Virchows Archiv A Pathol Anat 1992; 420: 345–51
- Murray P., Barrett-Lee P., Travers M., Luqmani Y., Powles T., Coombes R. The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 1993; 67: 1408–12
- Van Agthoven T., Timmermans M., Foekens J., Dorssers L, Henzen-Logmans S. Differential expression of estrogen, progesterone and epidermal growth factor receptors in normal, benign and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 1994; 144: 1238–46
- Nicholson R., McClelland R., Gee J., et al. Transforming growth factor-alpha and endocrine sensitivity in breast cancer. Cancer Res 1994; 54: 1684–9
- Manni A., Wright C., Buck H. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat 1991; 20: 43–52